HIV

Experimental treatment shows promise attacking tumor cells.

Ineffective antiretroviral regimens, improper dosing, and drug interactions are the most common medication errors in HIV patients.

Pharmacy schools may want to consider placing a greater focus on HIV education, since a new study suggests there's still HIV stigma among some pharmacy students.

The transition from an acute hospitalization back into the community introduces ample opportunities for medication errors, and HIV patients who need dosage adjustments and intense monitoring are particularly liable to them.

Patients with both HIV and cancer are less likely to receive treatment for common cancers, regardless of insurance status.

Knowing the details about new HIV diagnoses can help pharmacists better understand the infection.

What does your typical newly diagnosed HIV patient look like?

Needle exchange programs offer injection drug users a nonthreatening public location to bring a dirty needle and exchange it for a sterile one.

Borderline personality disorder leads to more risky sexual behavior, increasing the risk of HIV and other sexually transmitted diseases.

Women with HIV are more likely to get pregnant unintentionally.

Patients receiving same-day treatment for HIV were more likely to start antiretroviral therapy and had better viral suppression.

Paper device offers on-the-go inexpensive diagnosis of hepatitis C and HIV.

Potent broadly neutralizing antibody binds to HIV and causes a strong immune response.

Hepatitis B tends to be more aggressive in HIV patients, increasing the risk of cirrhosis, end-stage liver disease, and hepatocellular cancer.

Raltegravir may help boost adherence and help prevent vaginal HIV transmission.

Coinfection with hepatitis B virus isn't uncommon among those infected with HIV.

Broadly neutralizing antibodies were found to protect monkeys from an HIV-like virus.

Adherence to antiretroviral treatment negatively affected among patients with HIV who use drugs.

HIV continues to replicate in macrophages even without T-cells.

Study reports the second known real world data set for HCV patients coinfected with HIV treated with Sovaldi or Harvoni.

High prevalence of anti-HIV antibodies found in patients with hepatitis C and hepatitis B.

An HIV PrEP program would cost about $44 billion, but could prevent 21,500 new infections.

An HIV PrEP program would cost about $44 billion, but could prevent 21,500 new infections.

Mother-to-child transmission risk in women with HIV not impacted by herpes simplex virus.

Current HIV criminalization laws may be unfairly biased due to assumptions about intent to transmit the virus in sexual activity.